AVASTIN (bevacizumab) BLA 125085

by GENENTECH

attributevalue
Drug NameAVASTIN
Application Number125085
Active Ingredient(s)BEVACIZUMAB
CompanyGENENTECH
Dosages/Routes/Forms
Drug NameActive Ingredient(s)StrengthForm/RouteMarketing StatusRLDTE Code
AVASTINBEVACIZUMAB100MGVIAL; INTRAVENOUS10
AVASTINBEVACIZUMAB400MGVIAL; INTRAVENOUS10
Approval History
DateSupplement No.ActionDocuments
Mar 26, 2013267Labeling Revision
Jan 23, 2013263Efficacy Supplement with Clinical Data to Support
Nov 20, 2012265Labeling Revision
Oct 26, 2012239Efficacy Supplement with Clinical Data to Support
May 03, 20120238Supplement
Dec 20, 20110241Supplement
Sep 30, 2011225Supplement
Feb 22, 20080091Supplement
Feb 08, 2011208Supplement
Dec 28, 2010204Supplement
Feb 26, 2004000Approval
Jul 31, 20090168Supplement
May 05, 20090169Supplement
Mar 10, 20080145Supplement
Sep 20, 20070131Supplement
Oct 11, 20060085Supplement
Sep 21, 20060082Supplement
Jun 20, 20060074Supplement
Apr 18, 20060067Supplement
Sep 30, 20050045Supplement